BRG01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BRG01, covering 2024-05-08 to 2024-05-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma [Phase 1]